Company profile: HalioDx
1.1 - Company Overview
Company description
- Provider of diagnostic tests in oncology utilizing the immune contexture of cancers; designs and develops cancer diagnostics based on immune contexture.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to HalioDx
9 Meters Biopharma
HQ: United States
Website
- Description: Provider of a gastrointestinal platform focused on patients with rare disorders and unmet needs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full 9 Meters Biopharma company profile →
Ardelyx
HQ: United States
Website
- Description: Provider of oral therapeutics addressing mineral metabolism and metabolic disorders, including: RDX013, an investigational therapy for hyperkalemia via gut potassium secretion; RDX020, a research program targeting metabolic acidosis by inhibiting intestinal bicarbonate exchange; PHOZEVEL (tenapanor), approved in Japan for hyperphosphatemia; and IBSRELA (tenapanor), available in Canada for IBS-C.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ardelyx company profile →
Vigilant Biosciences
HQ: United States
Website
- Description: Provider of early cancer detection solutions focused on oral cancer, offering the BeVigilant OraFusion System that uses specific biomarkers to deliver semi-quantitative risk results (low, moderate, elevated), along with clinician resources for dental practices on diagnosis and treatment and patient education materials on risks, symptoms, and the importance of early detection.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vigilant Biosciences company profile →
Enyo Pharma
HQ: France
Website
- Description: Provider of biopharmaceutical therapies and discovery solutions, including Vonafexor (EYP001), a synthetic non-steroidal NR1H4 (FXR) agonist in Phase 2 for Alport syndrome, CKD, and NASH; EYP002, a first-in-class chemical series targeting mitochondrial NEET proteins; and a unique drug discovery platform based on biomimetism inspired by viruses.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Enyo Pharma company profile →
Furiex Pharmaceuticals
HQ: United States
Website
- Description: Provider of drug development collaboration and compound partnering services, working with pharmaceutical and biotechnology companies to enhance the value of their drug candidates through a novel development approach, focused on improving partnered drug programs primarily in the United States.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Furiex Pharmaceuticals company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for HalioDx
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to HalioDx
2.2 - Growth funds investing in similar companies to HalioDx
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for HalioDx
4.2 - Public trading comparable groups for HalioDx
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →